Fisheries Secy visits ornamental fish brood bank in Maharashtra (See 'Corp Brief') Company Law - For purpose of maintainability of petitions u/s 397 & 398, expression ‘member' is not to be confined only to formal entry in register of members u/s 41(2): SC (See 'Legal Desk') Over 3,500 Participants compete in AB PM-JAY Hackathon (See 'Corp Brief') Scindia, Fadnavis inaugurate renovated Andheri RS Post Office as Future-Ready Service Hub (See 'Corp Brief') IBC - While subsidiary companies are separate legal entities, corporate veil may be lifted if associated companies are inextricably connected so as to form one concern: SC (See 'Legal Desk') NHAI wins Arbitration Claim in Gujarat Project (See 'Corp Brief') India hosts ISO Subcommittee Meetings on 'Space Systems and Operations' (See 'Corp Brief') UIDAI Data Hackathon 2026 showcases Data-Driven Innovations for Inclusive Governance (See 'Corp Brief') NITI Aayog hosts workshop on Gender Equality (See 'Corp Brief') Ministry of Mines achieves Operationalization of 101 Auctioned Mineral Blocks (See 'Corp Brief') NIScPR signed an MoU with RIS to strengthen Science Technology Innovation Policy (See 'Corp Brief') SPA-designed Transformation begins at Nehru Place Post Office (See 'Corp Brief') IBC - corporate guarantees executed by corporate debtor in respect of loans advanced to group entities constitute 'financial debt' within meaning of Sec 5(8): SC (See 'Legal Desk') Women and SC/ST/OBC entrepreneurs lead PMEGP Success Story (See 'Corp Brief') IndiaAI and ICMR sign MoU to accelerate Responsible AI Adoption (See 'Corp Brief') Shifting of Trains to Upgraded Passenger Reservation System to begin in August (See 'Corp Brief') A&C - In absence of mandatory agreement to arbitrate, and where one party refuses to submit disputes to arbitration, Sec 11 application for appointment of arbitrator is not maintainable: SC (See 'Legal Desk') MoS presents certificates to first batch of Academicians in administration and governance (See 'Corp Brief') Atal Innovation Mission convenes AIM Sumvaad North to boost incubators (See 'Corp Brief') Multi-Organ Donation at Command Hospital, Chandimandir Saves Multiple Lives (See 'Corp Brief') IBC - Supreme Court directs NCLT Principal Bench and IBBI to furnish comprehensive nationwide data on pending approval applications and reasons for such delays: SC (See 'Legal Desk') Dr. Ravichandran inaugurates Urban Testbed and Aerosol Observatory in Chennai (See 'Corp Brief') Indian Steel Sector maintains Growth Momentum in April 2026 (See 'Corp Brief') BRICS Employment Working Group Meeting concludes in Thiruvananthapuram (See 'Corp Brief') IBC - No appeal can be filed in name of corporate debtor by suspended director claiming to be its authorised representative, once corporate insolvency resolution process has been admitted: SC (See 'Legal Desk') Centre approves FRP of Rs 365 per quintal for sugarcane (See 'Corp Brief') IIT-M's First Technology Summit Integrates AI Breakthroughs With Nation-Building (See 'Corp Brief') Centre Pushes Fast-Track Construction of Tribal Schools; Reviews Progress of 728 EMRS Projects (See 'Corp Brief') Cabinet approves Ship Repair Facility at Vadinar (See 'Corp Brief') A&C - Argument having not been raised before Sole Arbitrator, High Court at Sec 11 stage, Commercial Court u/s 34, or in pleadings of present appeal, cannot be permitted to be advanced orally at final stage: HC (See 'Legal Desk') Cabinet approves 3 multitracking projects covering 19 Districts (See 'Corp Brief') India-Japan cooperation in healthcare is guided by a shared vision: Nadda (See 'Corp Brief') Start-ups & MSMEs driving force to realise Viksit Bharat goal: MoS (See 'Corp Brief') A&C - If arbitration clause does not expressly specify seat of arbitration, does not identify definite venue, and does not contain exclusive jurisdiction clause, petition u/s 11(6) may be maintained: HC (See 'Legal Desk') BRO's Project Deepak celebrates 66th Raising Day (See 'Corp Brief') IPR - Appellant is a portal that reproduces university rankings & information available in public domain without alteration, editorial bias, or disparaging commentary - no interim injunction: HC (See 'Legal Desk') Capital Market - If allegation of insider trading under SEBI (PIT) Regulations, 2015 failed entirely, there is no contravention of SEBI Act: SAT (See 'Legal Desk') India witnesses Historic Expansion in Social Security: Mandaviya (See 'Corp Brief') Health Ministry releases RBSK 2.0 Guidelines at National Summit on Best Practices (See 'Corp Brief') NHAI successfully launches India's first Multi-Lane Free Flow Tolling System (See 'Corp Brief') IBC - Since MPID Act falls within State legislative field and attachment mechanism under MPID Act, especially where property already stands attached and vested in State, cannot be overridden by invoking Sec 238 or Sec 96 of IBC: HC (See 'Legal Desk') Goyal congratulates IIFT on 63rd Foundation Day (See 'Corp Brief') Outreach workshop on Atmanirbhar Panchayat Programme held at NIRD&PR, Hyderabad (See 'Corp Brief') Hyderabad should emerge as Global Hub for Yoga and Wellness: Reddy (See 'Corp Brief') IBC - If CIRP period expires without approved resolution plan, separate CoC resolution approving liquidation by 66% voting share is not required for Adjudicating Authority to order liquidation u/s 33(1)(a): NCLAT (See 'Legal Desk') Reining in Misuse of IBC for Recovery (See CORP EINSICHT)

Print

MoS reaffirms India's commitment to global pharmaceutical standardization

Published: Feb 06, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 06, 2025: UNION Minister of State for Health and Family Welfare, Anupriya Patel delivered the keynote address at the 15th International Meeting of World Pharmacopoeias (IMWP), hosted by the Indian Pharmacopoeia Commission (IPC) under the aegis of the Ministry of Health and Family Welfare, Government of India, in collaboration with the World Health Organization (WHO), here today. The meeting brought together global pharmacopoeial leaders, regulatory authorities, and industry stakeholders to deliberate on key issues related to pharmaceutical standards and harmonization.

Addressing the gathering, Patel reaffirmed India's commitment to global pharmaceutical standardization and regulatory convergence. She highlighted India's role as the "Pharmacy of the World" and emphasized the importance of ensuring access to high-quality medicines globally. She stated that the IMWP serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization.

On this occasion, the Union Minister also released the IPC Newsletter 2024 and a special IPC video film, which showcase India's advancements in pharmacopoeial science and the Commission's efforts in ensuring high-quality pharmaceutical standards. The video film can be accessed at the following link: https://www.youtube.com/watch?v=MCdAZodvOSM .

Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare, underscored the significance of global partnerships in strengthening pharmaceutical quality standards. She reiterated India's efforts in aligning regulatory frameworks with international best practices and ensuring the availability of safe and effective medicines worldwide.

Dr. Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, IPC, and Drugs Controller General (India), highlighted IPC's contributions in setting global benchmarks in pharmacopoeial science. He elaborated on IPC's initiatives, including the IP Online platform, which enhances accessibility and usability of Indian Pharmacopoeia standards. He emphasized the role of scientific advancements and regulatory cooperation in shaping global pharmaceutical standards.

Dr. Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasized the importance of regulatory harmonization in ensuring patient safety and public health.

The 15th IMWP is set to facilitate discussions on key focus areas, including:

- Updates on recommendations from the 14th IMWP and review of progress on harmonization initiatives.

- Emerging issues in impurity assessment (Q3) and the implications of ICH Q6 guidelines on pharmacopoeial monograph specifications.

- Defining the IMWP Charter to establish a long-term governance structure for the forum.

- Enhancing collaboration among global pharmacopoeias and regulatory bodies, with updates from the Pharmacopoeial Discussion Group (PDG).

- Promotion of environmental sustainability in pharmacopoeial practices and pharmaceutical manufacturing standards.

- Finalization of reports for the 15th IMWP and preparatory discussions for the 16th IMWP.

The deliberations during the IMWP will reinforce the role of pharmacopoeias in ensuring the quality, safety, and efficacy of medicines. The outcomes of the meeting will guide future collaborations in standard-setting and regulatory harmonization.

The 15th IMWP, which commenced today, will conclude on 7th February 2025. The discussions held over these three days will set the stage for further strengthening global pharmacopoeial cooperation and enhancing pharmaceutical quality assurance.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.